These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36258192)

  • 21. Investigation of Moral Hazard Deportments in Community-Based Health Insurance in Guto Gida District, Western Ethiopia: A Qualitative Study.
    Ayana ID
    Clinicoecon Outcomes Res; 2020; 12():733-746. PubMed ID: 33343200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of consumer and provider moral hazard at a municipal hospital out-patient department on Ghana's National Health Insurance Scheme.
    Yawson AE; Biritwum RB; Nimo PK
    Ghana Med J; 2012 Dec; 46(4):200-10. PubMed ID: 23661838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping evidence on the use of health promotion and disease prevention interventions as a strategy to sustaining pro-poor health insurance schemes: a scoping review protocol.
    Inkoom L; Ansu-Mensah M; Bawontuo V; Kuupiel D
    Syst Rev; 2022 Apr; 11(1):70. PubMed ID: 35422017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moral hazard in health insurance: are consumer-directed plans the answer?
    Farnsworth D
    Ann Health Law; 2006; 15(2):251-73, table of content. PubMed ID: 17554843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Albumin Usage in Iran.
    Rezapour A; Javan-Noughabi J; Salehiniya H; Kassani A; Sadeghi A
    Arch Iran Med; 2019 Dec; 22(12):722-727. PubMed ID: 31823624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iran's Health Transformation Plan; Main Issues and Opportunities for Improvement: A Systematic Review.
    Ghasemyani S; Raoofi S; Hamidi H; Khodayari-Zarnaq R
    Iran J Public Health; 2022 Sep; 51(9):1977-1989. PubMed ID: 36743374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial moral hazard and the theory of the second best.
    Frick KD; Chernew ME
    Inquiry; 2009; 46(2):229-40. PubMed ID: 19694395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approaches to pharmacy benefit management and the impact of consumer cost sharing.
    Olson BM
    Clin Ther; 2003 Jan; 25(1):250-72. PubMed ID: 12637125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The moral duty to buy health insurance.
    Rulli T; Emanuel EJ; Wendler D
    JAMA; 2012 Jul; 308(2):137-8. PubMed ID: 22782412
    [No Abstract]   [Full Text] [Related]  

  • 30. Is 'moral hazard' inefficient? The policy implications of a new theory.
    Nyman JA
    Health Aff (Millwood); 2004; 23(5):194-9. PubMed ID: 15371385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare professionals' moral distress in adult palliative care: a systematic review.
    Maffoni M; Argentero P; Giorgi I; Hynes J; Giardini A
    BMJ Support Palliat Care; 2019 Sep; 9(3):245-254. PubMed ID: 30636204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of cost-sharing in private health insurance on the utilization of health care services between private insurance purchasers and non-purchasers: a study of the Korean health panel survey (2008-2012).
    Choi Y; Kim JH; Yoo KB; Cho KH; Choi JW; Lee TH; Kim W; Park EC
    BMC Health Serv Res; 2015 Oct; 15():489. PubMed ID: 26510421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moral Hazard and the Demand for Dental Treatment: Evidence from a Nationally Representative Survey in Thailand.
    Srimuang K; Pholphirul P
    Int J Dent; 2022; 2022():2259038. PubMed ID: 36034478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ex-post moral hazard in the health insurance market: empirical evidence from German data.
    Thönnes S
    Eur J Health Econ; 2019 Dec; 20(9):1317-1333. PubMed ID: 31407102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moral hazard and prescription medicine use in Australia--the patient perspective.
    Doran E; Robertson J; Henry D
    Soc Sci Med; 2005 Apr; 60(7):1437-43. PubMed ID: 15652677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of elder abuse in Iran: a Systematic review and meta-analysis.
    Abdi A; Tarjoman A; Borji M
    Asian J Psychiatr; 2019 Jan; 39():120-127. PubMed ID: 30616159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective interventions for reducing moral distress in critical care nurses.
    Emami Zeydi A; Ghazanfari MJ; Suhonen R; Adib-Hajbaghery M; Karkhah S
    Nurs Ethics; 2022 Jun; 29(4):1047-1065. PubMed ID: 35081833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health insurance is associated with preventive care but not personal health behaviors.
    Jerant A; Fiscella K; Tancredi DJ; Franks P
    J Am Board Fam Med; 2013; 26(6):759-67. PubMed ID: 24204073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managed care and efficient rationing.
    Rosenthal MB; Newhouse JP
    J Health Care Finance; 2002; 28(4):1-10. PubMed ID: 12148660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moral hazard and the demand for health services: a matching estimator approach.
    Barros PP; Machado MP; Sanz-de-Galdeano A
    J Health Econ; 2008 Jul; 27(4):1006-1025. PubMed ID: 18406484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.